Rchr
J-GLOBAL ID:201901008820546985   Update date: Jun. 18, 2024

Hikino Keiko

Hikino Keiko
Affiliation and department:
Job title: Research Scientist
Research field  (2): Pharmacology ,  Genetics
Research keywords  (4): Pharmacogenomics ,  Clinical pharmacology ,  Population genetics ,  Pediatrics
Research theme for competitive and other funds  (6):
  • 2022 - 2024 Identifying genetic polymorphisms and elucidating polygenic architecture associated with adverse reactions due to rituximab
  • 2021 - 2024 Risk prediction and genetic elucidation of suicide using polygenic risk scores
  • 2022 - 2024 Investigation of genes related to severe hypogammaglobulinemia / agranulocytosis with rituximab and constructing a predictive model
  • 2023 - Comprehensive analysis of genetic factors and subjective response to alcohol in Japanese youths
  • 2021 - 2023 Genetic factors influencing voriconazole pharmacokinetics
Show all
Papers (23):
  • Keiko Hikino, Satoshi Koyama, Kaoru Ito, Yoshinao Koike, Masaru Koido, Takayoshi Matsumura, Ryo Kurosawa, Kohei Tomizuka, Shuji Ito, Xiaoxi Liu, et al. RNF213 Variants, Vasospastic Angina, and Risk of Fatal Myocardial Infarction. JAMA cardiology. 2024
  • Kensuke Shoji, Keiko Hikino, Jumpei Saito, Toshihiro Matsui, Tomoyuki Utano, Akira Takebayashi, Daisuke Tomizawa, Motohiro Kato, Kimikazu Matsumoto, Takashi Ishikawa, et al. Pharmacogenetic implementation for CYP2C19 and pharmacokinetics of voriconazole in children with malignancy or inborn errors of immunity. Journal of Infection and Chemotherapy. 2024
  • Shuji Ito, Hiroshi Takuwa, Saori Kakehi, Yuki Someya, Hideyoshi Kaga, Nobuyuki Kumahashi, Suguru Kuwata, Takuya Wakatsuki, Masaru Kadowaki, Soichiro Yamamoto, et al. A genome-wide association study identifies a locus associated with knee extension strength in older Japanese individuals. Communications Biology. 2024
  • Mark Purdue, Diptavo Dutta, Mitchell J. Machiela, Bryan Gorman, Timothy Winter, Dayne Okuhara, Sara Cleland, Aida Ferreiro-Iglesias, Paul Scheet, Aoxing Liu, et al. Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nature Genetics. 2024
  • Xiaoxi Liu, Satoshi Koyama, Kohei Tomizuka, Sadaaki Takata, Yuki Ishikawa, Shuji Ito, Shunichi Kosugi, Kunihiko Suzuki, Keiko Hikino, Masaru Koido, et al. Decoding triancestral origins, archaic introgression, and natural selection in the Japanese population by whole-genome sequencing. Science Advances. 2024
more...
Professional career (2):
  • MD (Shimane University)
  • PhD (Yokohama City University)
Work history (6):
  • 2024/04 - 現在 RIKEN Center for Integrative Medical Sciences, Laboratory for Pharmacogenomics, Research Scientist
  • 2020/10 - 2024/03 RIKEN Center for Integrative Medical Sciences, Laboratory for Pharmacogenomics, Postdoctoral Researcher
  • 2016/07 - 2020/09 RIKEN Center for Integrative Medical Sciences, Laboratory for Pharmacogenomics, Research Associate
  • 2014/08 - 2016/07 University of Chicago, Committee on Clinical Pharmacology and Pharmacogenomics, Fellow
  • 2013/07 - 2016/06 University of Chicago, Pediatric Critical Care Medicine, Fellow
Show all
Awards (6):
  • 2023/03 - Award for FY2022 Performance Incentives of Integrative Medical Sciences, RIKEN
  • 2022/12 - ASHG 2022 Annual Meeting Travel Award at the Japanese Society of Human Genetics 2022 Annual Meeting
  • 2022/08 - Reviewers’ Choice Abstract Award at the American Society of Human Genetics 2022 Annual Meeting
  • 2022/03 - Award for FY2021 Performance Incentives of Integrative Medical Sciences, RIKEN
  • 2013/06 - Faculty Award for Academic Excellence, Pediatric Residency Program, University of Hawaii
Show all
Association Membership(s) (6):
THE AMERICAN SOCIETY OF HUMAN GENETICS ,  THE JAPAN SOCIETY OF HUMAN GENETICS ,  AMERICAN SOCIETY OF CLINICAL PHARMACOLOGY AND THERAPEUTICS ,  THE JAPANESE SOCIETY OF CLINICAL PHARMACOLOGY AND THERAPEUTICS ,  AMERICAN ACADEMY OF PEDIATRICS ,  JAPAN PEDIATRIC SOCIETY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page